AdAlta and The University of Melbourne to develop i-bodies for the treatment of various eye diseases
Read MoreNews & Media – old
Japanese patent granted for AdAlta i-body technology
Read MoreAdAlta appoints Dr Paul MacLeman Chairman
Read MoreAdAlta expands its scientific advisory team
Read MoreAdAlta expands its scientific advisory team
Read MoreLonza and AdAlta Announce a Strain Development Contract for Novel Biologic Therapeutics
Read MoreAdAlta collaborates with Crossbeta to find i-body for Alzheimer’s disease
Read MoreAdAlta awarded voucher to explore benefits of technologies with Ferring Research Institute
Read MoreAdAlta and Baker IDI sign agreement to identify i-bodies to anti-thrombotic target
Read MoreAdAlta and Roche sign agreement to evaluate shark antibody technology
Read More
